111 related articles for article (PubMed ID: 11102987)
1. Polymorphisms in a pseudogene highly homologous to PMS2.
Chadwick RB; Meek JE; Prior TW; Peltomaki P; de La Chapelle A
Hum Mutat; 2000 Dec; 16(6):530. PubMed ID: 11102987
[TBL] [Abstract][Full Text] [Related]
2. Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.
Vaughn CP; Hart KJ; Samowitz WS; Swensen JJ
Hum Mutat; 2011 Sep; 32(9):1063-71. PubMed ID: 21618646
[TBL] [Abstract][Full Text] [Related]
3. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
[TBL] [Abstract][Full Text] [Related]
4. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.
Etzler J; Peyrl A; Zatkova A; Schildhaus HU; Ficek A; Merkelbach-Bruse S; Kratz CP; Attarbaschi A; Hainfellner JA; Yao S; Messiaen L; Slavc I; Wimmer K
Hum Mutat; 2008 Feb; 29(2):299-305. PubMed ID: 18030674
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.
De Rosa M; Fasano C; Panariello L; Scarano MI; Belli G; Iannelli A; Ciciliano F; Izzo P
Oncogene; 2000 Mar; 19(13):1719-23. PubMed ID: 10763829
[TBL] [Abstract][Full Text] [Related]
7. Extensive gene conversion at the PMS2 DNA mismatch repair locus.
Hayward BE; De Vos M; Valleley EM; Charlton RS; Taylor GR; Sheridan E; Bonthron DT
Hum Mutat; 2007 May; 28(5):424-30. PubMed ID: 17253626
[TBL] [Abstract][Full Text] [Related]
8. Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.
De Vos M; Hayward BE; Picton S; Sheridan E; Bonthron DT
Am J Hum Genet; 2004 May; 74(5):954-64. PubMed ID: 15077197
[TBL] [Abstract][Full Text] [Related]
9. A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation.
Nomura S; Fujimoto Y; Yamamoto N; Sato Y; Ashihara Y; Kita M; Yamaguchi J; Ishikawa Y; Ueno M; Arai M
Jpn J Clin Oncol; 2015 Oct; 45(10):987-92. PubMed ID: 26232782
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.
Vaughn CP; Robles J; Swensen JJ; Miller CE; Lyon E; Mao R; Bayrak-Toydemir P; Samowitz WS
Hum Mutat; 2010 May; 31(5):588-93. PubMed ID: 20205264
[TBL] [Abstract][Full Text] [Related]
11. Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells.
Shin CY; Mellon I; Turker MS
Oncogene; 2002 Mar; 21(11):1768-76. PubMed ID: 11896608
[TBL] [Abstract][Full Text] [Related]
12. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.
Prolla TA; Baker SM; Harris AC; Tsao JL; Yao X; Bronner CE; Zheng B; Gordon M; Reneker J; Arnheim N; Shibata D; Bradley A; Liskay RM
Nat Genet; 1998 Mar; 18(3):276-9. PubMed ID: 9500552
[TBL] [Abstract][Full Text] [Related]
13. Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.
Auclair J; Leroux D; Desseigne F; Lasset C; Saurin JC; Joly MO; Pinson S; Xu XL; Montmain G; Ruano E; Navarro C; Puisieux A; Wang Q
Hum Mutat; 2007 Nov; 28(11):1084-90. PubMed ID: 17557300
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the 5' region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene.
Nicolaides NC; Kinzler KW; Vogelstein B
Genomics; 1995 Sep; 29(2):329-34. PubMed ID: 8666379
[TBL] [Abstract][Full Text] [Related]
15. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.
Nicolaides NC; Papadopoulos N; Liu B; Wei YF; Carter KC; Ruben SM; Rosen CA; Haseltine WA; Fleischmann RD; Fraser CM
Nature; 1994 Sep; 371(6492):75-80. PubMed ID: 8072530
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.
Li J; Dai H; Feng Y; Tang J; Chen S; Tian X; Gorman E; Schmitt ES; Hansen TA; Wang J; Plon SE; Zhang VW; Wong LJ
J Mol Diagn; 2015 Sep; 17(5):545-53. PubMed ID: 26320870
[TBL] [Abstract][Full Text] [Related]
17. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice.
Yao X; Buermeyer AB; Narayanan L; Tran D; Baker SM; Prolla TA; Glazer PM; Liskay RM; Arnheim N
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6850-5. PubMed ID: 10359802
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts.
Andrew SE; Xu XS; Baross-Francis A; Narayanan L; Milhausen K; Liskay RM; Jirik FR; Glazer PM
Carcinogenesis; 2000 Jul; 21(7):1291-5. PubMed ID: 10874005
[TBL] [Abstract][Full Text] [Related]
19. Assay validation for identification of hereditary nonpolyposis colon cancer-causing mutations in mismatch repair genes MLH1, MSH2, and MSH6.
Hegde M; Blazo M; Chong B; Prior T; Richards C
J Mol Diagn; 2005 Oct; 7(4):525-34. PubMed ID: 16237223
[TBL] [Abstract][Full Text] [Related]
20. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.
van der Klift HM; Tops CM; Bik EC; Boogaard MW; Borgstein AM; Hansson KB; Ausems MG; Gomez Garcia E; Green A; Hes FJ; Izatt L; van Hest LP; Alonso AM; Vriends AH; Wagner A; van Zelst-Stams WA; Vasen HF; Morreau H; Devilee P; Wijnen JT
Hum Mutat; 2010 May; 31(5):578-87. PubMed ID: 20186688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
